Compare CTSO & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTSO | ATCX |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9M | 20.0M |
| IPO Year | 2008 | 2016 |
| Metric | CTSO | ATCX |
|---|---|---|
| Price | $0.39 | $3.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.38 | ★ $13.75 |
| AVG Volume (30 Days) | ★ 58.7K | 10.9K |
| Earning Date | 05-01-2026 | 03-16-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $22,503,908.00 | N/A |
| Revenue This Year | $10.34 | $827,667.00 |
| Revenue Next Year | $22.41 | $166.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.35 | $2.57 |
| 52 Week High | $1.19 | $14.01 |
| Indicator | CTSO | ATCX |
|---|---|---|
| Relative Strength Index (RSI) | 52.89 | 53.09 |
| Support Level | $0.36 | $2.68 |
| Resistance Level | $0.40 | $3.81 |
| Average True Range (ATR) | 0.03 | 0.23 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 80.00 | 81.93 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.